跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Gadovist - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Gadovist
Approved
STANDARD
Gadovist
Bayer AG
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e231bb12141a6c04
Company
Bayer AG
Type
Standard
Approval Details
Approval Id
e231bb12141a6c04
Drug Approval Philippines Name
Gadovist
Product Name
Gadovist
Registration Number
DR-XY38878
Brand Name
Gadovist
Generic Name
Gadobutrol
Dosage Form
Solution For Intravenous Injection
Dosage Strength
1 mmol/mL (equivalent to 604.72 mg/mL)
Manufacturer
Bayer AG
Importer
Bayer Philippines, Inc.
Company Detail Path
/organization/bayer-ag
Issuance Date
24 August 2023
Expiry Date
24 August 2028
Pharmacologic Category
Paramagnetic Contrast Media
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e231bb12141a6c04
Type
Standard
Back to Philippines FDA Approvals